BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Friday, April 19, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
March 22, 2012
View Archived Issues
Merck & Co. uncovers gene polymorphisms linked to MK-7246 pharmacokinetics
Read More
Fate Therapeutics discloses new hedgehog pathway activators
Read More
Canadian university patents new SHIP-1 modulators
Read More
Novartis discloses updated phase II data on secukinumab
Read More
Cardium Therapeutics begins phase III registration study
Read More
Korean trials assess two Lapscovery-based drugs
Read More
Galapagos receives milestone payment from Janssen Pharmaceutica
Read More
Addex Pharmaceuticals changes name
Read More
Ablynx extends global strategic Nanobody alliance
Read More
Abbott discloses new name for future research-based company
Read More
Medistem updates on endometrial regenerative cell therapy development
Read More
Treatment begins in global phase II/III hemophilia B trial
Read More
Flagyl approved for additional indication in Japan
Read More
NCI study reveals novel candidate biomarkers of hepatocellular carcinoma
Read More
Health Canada approves grass pollen immunotherapy
Read More
Green Cross clear to conduct GreenGene F study in U.S.
Read More
Merck & Co. presents new potential cancer therapies
Read More
Novel chemokine CCR4 receptor antagonists developed at GSK
Read More
New tyrosine-protein kinase inhibitors reported
Read More
Chroma Therapeutics designs new histone deacetylase inhibitors
Read More
Allergan scientists discover novel prostanoid receptor antagonists
Read More
Cerus gives update on INTERCEPT Blood System
Read More
Line extension for Taxol approved in Japan
Read More
Enrollment complete in phase II MN-221 trial
Read More
Noven completes phase III program for low-dose paroxetine mesilate
Read More